At AbbVie, we’re passionate about combining advanced science with a deep knowledge of the patient experience and worldwide health care systems to help people live better, more productive lives.
AbbVie is extremely proud to support patient care through the provision of grants to healthcare and patient organisations. In addition, we take pride in helping to subsidise the cost of ongoing learning of NHS healthcare professionals (HCPs) by providing financial support to attend independent third-party medical educational events and conferences. We feel this is aligned to our commitment to support HCPs, and ultimately the health and wellbeing of the patients they serve.
Collaboration of industry with healthcare organisations, patient organisations and HCPs is essential to advance patient care, gain insights into unmet medical needs and progress the development of new medicines.
Transparency is key to ensuring that HCPs and organisations can continue to collaborate to bring new, innovative treatments to patients while ensuring that concerns about the relationship and payments (to reimburse them for their time and expertise) between HCPs/patient organisations and industry are addressed.
In accordance with the Association of the British Pharmaceutical Industry (ABPI) Code of Practice, AbbVie’s disclosure of funding support is published here:
- January 2015 - December 2015 (Patient Organisations)
- January 2015 - December 2015 (2014 ToVs to HCP & HCO paid in 2015)
- January 2014 - December 2014
From 2016, the ABPI requires that its members disclose payments to healthcare organisations and health professionals. AbbVie’s records of 2015 payments may be found in the public database at http://www.disclosureuk.org.uk/.
If you are an HCP and have an enquiry related to the transparency initiative, please send an email to UK.Transparency@abbvie.com
Annually, AbbVie publishes a list of its financial support of European Patient Organisations. Our publication of the following report demonstrates our commitment to transparent disclosure of our financial relationships with patient organisations.